Rhett Johnson

Vice President

Rhett Johnson has over 25 years of consulting experience, assisting life sciences clients develop commercialization strategies that generate a sustainable competitive advantage in a complex and constantly evolving healthcare marketplace. Areas of focus include corporate growth strategy, asset evaluations and product strategy, pricing and market access, analytics and forecasting, and competitive analysis.

Mr. Johnson joined CRA as an Associate after studying economics at the University of Chicago. Mr. Johnson now co-leads CRAs Global Life Sciences Strategy Consulting team, with responsibility for innovation and practice growth.

Selected engagements

  • 01
    Payer reactions to 2024 IRA MFP negotiations and implications for access strategy
    A leading pharmaceutical company sought support in understanding payer reactions to the 2024 IRA MFP negotiations and implications for Commercial plan
    View engagement
  • 02
    Developed dynamic GTN model to guide pricing and contracting strategy for a rare disease asset
    A leading pharmaceutical company engaged CRA’s Life Sciences consultants for support in developing a pricing and contracting strategy for a rare disease asset
    View engagement
  • 03
    Understanding the PMA potential of future innovations in oncology
    A leading pharmaceutical company sought support from CRA Life Sciences experts in the clinical development of several new monotherapy and combination products
    View engagement

Credentials